<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326076</url>
  </required_header>
  <id_info>
    <org_study_id>KOAR</org_study_id>
    <nct_id>NCT03326076</nct_id>
  </id_info>
  <brief_title>Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry</brief_title>
  <acronym>KOAR</acronym>
  <official_title>Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CareDx</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CareDx</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study to evaluate safety and efficacy outcomes in renal transplant
      recipients in whom post-transplant care is managed using AlloSure®. AlloSure® is a
      non-invasive test to measure donor-derived cell-free DNA (dd-cfDNA). The AlloSure test is
      intended to assess the probability of allograft rejection in kidney transplant recipients
      with clinical suspicion of rejection and to inform clinical decision-making regarding the
      necessity of renal biopsy in such patients at least 2 weeks post-transplant in conjunction
      with standard clinical assessment.

      Amendment 1 (A1): Is an observational study to develop and validate the clinical use of
      KidneyCare®.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The AlloSure test has been approved for Medicare coverage for clinical use when a physician
      determines there is a need to assess the probability of allograft rejection in kidney
      transplant recipients. The DART study suggests that use of the non-invasive AlloSure test to
      measure donor-derived cell-free DNA (dd-cfDNA) can be used to discriminate active rejection
      in a renal transplant recipient. Use of the test may reduce invasive percutaneous renal
      biopsy procedures among patients with a suspicion of rejection.

      Amendment 1 (A1) is intended to enable the development of KidneyCare® which is a panel test
      which includes the clinically validated commercial AlloSure dd-cfDNA test, combined with
      AlloMap Kidney which is a peripheral blood gene expression profiling test currently under
      development, and iBox, which is an analytic platform that predicts allograft survival at 3,
      5, 7 and 10 years using a proprietary software algorithm based on a number of clinical
      inputs. The AlloMap Kidney and the iBox components are not yet clinically validated and so
      will not be used for patient management and are being developed through this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 23, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Interstitial fibrosis/tubular atrophy (IF/TA) quantified by Banff Working Group biopsy grade(s) at 12 months post-transplant in AlloSure® and renal allograft biopsy managed patients</measure>
    <time_frame>Feb-2020</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total number of biopsies planned and performed post-transplant, including both surveillance and clinically indicated biopsies</measure>
    <time_frame>Feb-2020</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transplant glomerulopathy (TG)</measure>
    <time_frame>Dec-2022</time_frame>
    <description>Evaluated at one-year post-transplant, quantified by biopsy-based histopathology grade(s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient and graft survival</measure>
    <time_frame>Dec-2022</time_frame>
    <description>Evaluated at years 1, 2, and 3 post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>Dec-2022</time_frame>
    <description>Evaluated at years 1, 2, and 3 post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated glomerular filtration rate</measure>
    <time_frame>Dec-2022</time_frame>
    <description>Evaluated at years 1, 2, and 3 post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of AlloSure for active rejection</measure>
    <time_frame>Dec-2022</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of AlloSure for active rejection</measure>
    <time_frame>Dec-2022</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative Predictive Value (NPV) of AlloSure for active rejection</measure>
    <time_frame>Dec-2022</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive Predictive Value (PPV) of AlloSure for active rejection</measure>
    <time_frame>Dec-2022</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Develop and validate the clinical use of KidneyCare®</measure>
    <time_frame>Dec-2022</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Kidney Transplant Rejection</condition>
  <arm_group>
    <arm_group_label>Primary donor-derived cell-free DNA</arm_group_label>
    <description>300 patients with planned renal surveillance biopsies at 12 months post-transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>A matched control cohort of 1000 patients with planned renal surveillance biopsies at 12 months post-transplantation but were not managed with donor-derived cell-free DNA (AlloSure®) or KidneyCare will be retrospectively selected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary donor-derived cell-free DNA</arm_group_label>
    <description>1200 patients without planned renal surveillance biopsies at 12 months post-transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary KidneyCare®</arm_group_label>
    <description>300 patients with planned renal surveillance biopsies at 12 months post-transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary KidneyCare®</arm_group_label>
    <description>1200 patients without planned renal surveillance biopsies at 12 months post-transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Donor-derived cell-free DNA (AlloSure®)</intervention_name>
    <description>Patients will receive donor-derived cell-free DNA testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.</description>
    <arm_group_label>Primary KidneyCare®</arm_group_label>
    <arm_group_label>Primary donor-derived cell-free DNA</arm_group_label>
    <arm_group_label>Secondary KidneyCare®</arm_group_label>
    <arm_group_label>Secondary donor-derived cell-free DNA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Current standard methods for monitoring of renal allograft recipients for rejection (e.g. donor-specific antibodies, serum creatinine, proteinuria, renal allograft biopsy)</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Peripheral blood gene expression profiling (AlloMap Kidney)</intervention_name>
    <description>Patients will receive peripheral blood gene expression profiling testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.</description>
    <arm_group_label>Primary KidneyCare®</arm_group_label>
    <arm_group_label>Secondary KidneyCare®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Analytic platform (IBox)</intervention_name>
    <description>Patients will receive IBox testing for surveillance and for-cause. The planned surveillance will occur at months 1, 2, 3, 4, 6, 9, and 12 post-transplant and quarterly in year 2 and year 3.</description>
    <arm_group_label>Primary KidneyCare®</arm_group_label>
    <arm_group_label>Secondary KidneyCare®</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma from venous blood will be collected and cell-free DNA will be extracted from the
      plasma for analysis of donor-derived cell-free DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible renal transplant recipients who meet the inclusion/exclusion criteria will be
        a part of this observational study.

        The control cohort will include the patients cared for without the use of AlloSure® or
        KidneyCare at the participating centers who received their transplant in the 6 months prior
        to the enrollment start for the primary cohort.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        KOAR Inclusion Criteria:

          1. Medicare-covered (Part B) renal transplant recipients selected by their providers to
             receive AlloSure testing as part of their practical care beginning by 2 months
             post-transplantation.

          2. Patient's health care provider adopts and intends to apply the center's AlloSure
             Routine Testing Schedule as part of the information used to manage the patient.

          3. Subjects willing to provide written informed consent to participate.

        KOAR Exclusion Criteria:

        1. Renal transplant recipients without Medicare (Part B) coverage.

        ___________________________________________________________

        Exclusions for AlloSure® Intended Use

        Specimens from patients for whom any of the following are true will not be tested:

          1. Recipients of transplanted organs other than kidney

          2. Recipients of a transplant from a monozygotic (identical)

          3. Recipients of a bone marrow transplant

          4. Recipients who are pregnant

          5. Recipients who are under the age of 18

          6. Recipient who are less than 14 days post-transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sham Dholakia</last_name>
    <phone>415-287-2374</phone>
    <email>sdholakia@caredx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alana Burns</last_name>
    <phone>415-287-2420</phone>
    <email>aburns@caredx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Scavone</last_name>
    </contact>
    <investigator>
      <last_name>Rafael Villicana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nori Ammerman</last_name>
      <email>Noriko.Ammerman@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Edmund Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90089</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Rios</last_name>
    </contact>
    <investigator>
      <last_name>Thin Thin Maw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janette Gadzhyan</last_name>
      <phone>310-794-8516</phone>
      <email>JGadzhyan@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Suphamai Bunnapradist, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Howes</last_name>
      <phone>916-734-4009</phone>
      <email>khowes@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Yihung Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daksshi Hettiarachichi</last_name>
      <email>daksshi.hettiarachchi@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Ramesh Batra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgetown University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takada Harris</last_name>
      <email>Takada.M.Harris@gunet.georgetown.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Cooper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington University</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Andrews</last_name>
      <email>scandrews@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Muralidharan Jagadeesan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami/Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Fernandez</last_name>
      <email>i.fernandez6@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>George Burke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherri Loeb</last_name>
      <email>Sherri_t_loeb@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Oyedolamu Olaitan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyotsna Soundararajan</last_name>
      <email>jsoundararajan@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Pratik Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ted Clevy-Schneller</last_name>
      <email>Ted.Clevy-schneller@luhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Sana Iqbal</last_name>
      <phone>708-216-3268</phone>
      <email>siqbal5@luc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Amishi Desai, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjeev Akkina, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Adebiyi</last_name>
      <phone>317-948-0633</phone>
      <email>madebiyi@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Asif Sharfuddin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Delaney</last_name>
      <phone>913-588-3520</phone>
      <email>edelaney@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Klein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Lassair</last_name>
      <phone>504-988-2882</phone>
      <email>nlassair@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>Anil Paramesh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ochsner Foundation Hospital</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Smith</last_name>
      <phone>504-703-5606</phone>
      <email>anglsmith@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Zohreh Soltani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Bartosic</last_name>
      <phone>410-328-0303</phone>
      <email>ABartosic@som.umaryland.edu</email>
    </contact>
    <contact_backup>
      <last_name>Veronica Brown</last_name>
      <phone>410-328-0303</phone>
      <email>VLBrown@som.umaryland.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Bromberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Ogir</last_name>
      <email>sogir1@jhu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Darin Ostrander</last_name>
      <email>dostran1@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Brennan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret V Thomas</last_name>
      <phone>617-643-6266</phone>
      <email>MVTHOMAS@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Hannah Gilligan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan McDermott</last_name>
      <email>smcderm2@bidmc.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Amtul Aala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delia Owens</last_name>
      <email>dyowens@umc.edu</email>
    </contact>
    <investigator>
      <last_name>Iasmina Craici, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devin Wall</last_name>
      <phone>314-362-4109</phone>
      <email>devinwall@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Malone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carrie Fay</last_name>
      <email>carrie.fay@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Langewisch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Barnabus Medical Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nasreen Ali</last_name>
      <phone>973-322-5392</phone>
      <email>nasreen.ali@rwjbh.org</email>
    </contact>
    <investigator>
      <last_name>Anup Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Mohammed</last_name>
      <phone>347-671-8217</phone>
      <email>OMOHAMME@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Enver Akalin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seema Chittalae</last_name>
      <email>Seema.Chittalae@downstate.edu</email>
    </contact>
    <investigator>
      <last_name>Mariana Markell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erie County Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Wittek</last_name>
      <email>dwittek@ecmc.edu</email>
    </contact>
    <investigator>
      <last_name>Liise Kayler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>22705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Ramos</last_name>
      <email>jose.ramos@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Stuart Knechtle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Carolina University/Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josh Yang</last_name>
      <phone>252-744-0114</phone>
      <email>YANGJ15@ECU.EDU</email>
    </contact>
    <investigator>
      <last_name>David Leeser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priscilla Dann</last_name>
    </contact>
    <contact_backup>
      <last_name>Leslie Cooperman</last_name>
    </contact_backup>
    <investigator>
      <last_name>Emilio Poggio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Oklahoma Transplant Center at OU Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Choate</last_name>
      <phone>405-271-2498</phone>
      <email>Julie.choate@oumedicine.com</email>
    </contact>
    <investigator>
      <last_name>Alan Hawxby, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Integris Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarey Coldren</last_name>
      <phone>405-713-7432</phone>
      <email>Tarey.Coldren@integrisok.com</email>
    </contact>
    <investigator>
      <last_name>Kristopher Lepere, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Neubauer</last_name>
      <phone>215-615-0773</phone>
      <email>Robin.Neubauer@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Roy Bloom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Svetlana Bondar</last_name>
      <phone>412-359-4026</phone>
      <email>Svetlana.bondar@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Kalathil Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Fedorek</last_name>
      <phone>412-692-2207</phone>
      <email>fedoreksp@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Puneet Sood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce McKenney Goulart</last_name>
      <phone>401-444-8598</phone>
      <email>Joyce.MckenneyGoulart@Lifespan.org</email>
    </contact>
    <investigator>
      <last_name>Reginald Gohh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37292</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Malia Reed</last_name>
      <phone>615-936-1182</phone>
      <email>malia.reed@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Anthony Langone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samita Kumar</last_name>
      <email>Samita.Kumar@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Malcolm MacConmara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor All Saints Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Texas Research Institute</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mano Ellappan</last_name>
      <email>mellappan@ppghealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Sridhar Allam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Medical Center</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Kossie</last_name>
      <phone>254-935-5838</phone>
      <email>Ashley.Kossie@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Mohanram Narayanan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Lamph</last_name>
      <email>Amber.Lamph@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Fuad Shihab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Percy Julian</last_name>
      <phone>703-776-3505</phone>
      <email>Percy.Julian@inova.org</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Wright</last_name>
      <phone>703-776-3778</phone>
      <email>Sarah.Wright@inova.org</email>
    </contact_backup>
    <investigator>
      <last_name>James B Piper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Ruddley</last_name>
      <phone>804-828-9684</phone>
      <email>joyce.ruddley@vcuhealth.org</email>
    </contact>
    <investigator>
      <last_name>Dhiren Kumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katie Crawford</last_name>
      <phone>509-474-4302</phone>
      <email>Katie.crawford@providence.org</email>
    </contact>
    <investigator>
      <last_name>Samer BaniHani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators. Cell-Free DNA and Active Rejection in Kidney Allografts. J Am Soc Nephrol. 2017 Jul;28(7):2221-2232. doi: 10.1681/ASN.2016091034. Epub 2017 Mar 9.</citation>
    <PMID>28280140</PMID>
  </reference>
  <reference>
    <citation>Grskovic M, Hiller DJ, Eubank LA, Sninsky JJ, Christopherson C, Collins JP, Thompson K, Song M, Wang YS, Ross D, Nelles MJ, Yee JP, Wilber JC, Crespo-Leiro MG, Scott SL, Woodward RN. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients. J Mol Diagn. 2016 Nov;18(6):890-902. doi: 10.1016/j.jmoldx.2016.07.003. Epub 2016 Oct 7.</citation>
    <PMID>27727019</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

